InterventionsHumans

SGLT2 Inhibitors and Long-Term Outcomes in Kidney Transplant Recipients: A Propensity-Matched Cohort Study

AHA Scientific Sessions 2025 Abstract

The paper

Esteghamati S, Kamel I, Mahmoud A et al.

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4339322

doi.org/10.1161/circ.152.suppl_3.4339322

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
Clinical Pharmacology and Therapeutics · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026